These data demonstrate that the expansion of NCR− ILC3s is concomitant with the expansion of IL‐17A–producing T cells within JIA SFMCs, which indicates that the cell‐specific contribution to the IL‐17A milieu in JIA SFMCs may be a key determinant of clinical outcome. The gene discussed is IL17A; the disease is juvenile idiopathic arthritis.